NDC Package 67877-444-90 Dalfampridine

Tablet, Film Coated, Extended Release Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
67877-444-90
Package Description:
90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
Product Code:
Proprietary Name:
Dalfampridine
Non-Proprietary Name:
Dalfampridine
Substance Name:
Dalfampridine
Usage Information:
Dalfampridine is used to improve walking in people with multiple sclerosis (MS). It is a potassium channel blocker. It is thought to work by improving nerve conduction.
11-Digit NDC Billing Format:
67877044490
NDC to RxNorm Crosswalk:
  • RxCUI: 897021 - dalfampridine 10 MG 12HR Extended Release Oral Tablet
  • RxCUI: 897021 - 12 HR dalfampridine 10 MG Extended Release Oral Tablet
  • RxCUI: 897021 - dalfampridine 10 MG 12 HR Extended Release Oral Tablet
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Ascend Laboratories, Llc
    Dosage Form:
    Tablet, Film Coated, Extended Release - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA206765
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    07-31-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    67877-444-05500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
    67877-444-6060 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 67877-444-90?

    The NDC Packaged Code 67877-444-90 is assigned to a package of 90 tablet, film coated, extended release in 1 bottle of Dalfampridine, a human prescription drug labeled by Ascend Laboratories, Llc. The product's dosage form is tablet, film coated, extended release and is administered via oral form.

    Is NDC 67877-444 included in the NDC Directory?

    Yes, Dalfampridine with product code 67877-444 is active and included in the NDC Directory. The product was first marketed by Ascend Laboratories, Llc on July 31, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 67877-444-90?

    The 11-digit format is 67877044490. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-267877-444-905-4-267877-0444-90